← Leaderboards
Rashim Singh
Sanarentero Llc
$661,985
Attributed
$1,231,954
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $452K · FY2020–23$500K$375K$250K$125K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$1,231,954 · 3
By mechanism
R41$854,954 · 2
R43$377,000 · 1
Top collaborators
- Ming Hu3 shared
- Xiaoqiang Wang2 shared
- Tsz Yan Clement Chan1 shared
Others in their field
Other Emerging Leaders on “Toxic Effect”
- Matthew Johnson · Duke University$56,071,536
- John Damon Chodera · Sloan-Kettering Inst Can Research$25,853,758
- Kristin Aillon · Midwest Research Institute$24,228,962
- Bronwen Shaw · Medical College Of Wisconsin$19,182,557
- Xinhua Li · Nano Terra, Inc.$17,491,533
- Thomas Denny · Duke University$16,626,143
Research focus
Toxic EffectDiarrheaSuccessCancer PatientIntestinesSafetyNovel TherapeuticsSn-38CapsuleIrinotecanPharmaceutical PreparationsPreventFreeze DryingQuality Of LifeChemotherapyDoseSmall Business Innovation Research GrantPreventionSide EffectClinicInnovationDose-LimitingMedicalDisseminated Malignant Neoplasm
Grant awards (5)
Genetic Biocontainment Switch to Improve the Safety of Drug Detoxifying Bacteria in Preventing Chemotherapy-induced Diarrhea$399,999
R41 · FY2023 · CA · contact PI
Development of Drug Detoxifying Bacteria for Chemotherapy Induced Gut Injury$55,000
R41 · FY2022 · CA · contact PI
Development of Drug Detoxifying Bacteria for Chemotherapy Induced Gut Injury$399,955
R41 · FY2021 · CA · contact PI
Development of Novel Herbal Therapy for Prevention of Irinotecan-induced Severe Delayed Onset Diarrhea$52,000
R43 · FY2021 · AT · contact PI
Development of Novel Herbal Therapy for Prevention of Irinotecan-induced Severe Delayed Onset Diarrhea$325,000
R43 · FY2020 · AT · contact PI